Diabetes Drugs Turned Weight Loss Wonders: GLP1 Agonists Achieve Up to 8% Body Weight Loss

All about the upcoming arrival of the Wegobi weight loss shot in Israel

Novo Nordisk has developed weight loss injections that were originally intended for diabetics. These injections, known as GLP1 agonists, mimic a hormone that lowers blood sugar levels and promotes weight loss through various mechanisms in the body.

The first injection, Saxenda, led to an 8% loss of body weight. Following this was Ozempic and Vigobi, which were even more effective for weight loss. The Vigobi injection, with a dosage of 2.4 milligrams, is taken gradually to reduce side effects and will be available in pharmacies, prescribed by private doctors. The cost ranges from NIS 600 to NIS 1,250 depending on the dosage.

While these injections can help with weight loss, it is important to note that a healthy lifestyle including proper nutrition and exercise is essential for long-term success. Treatment with weight loss injections can be continued as long as necessary and may be stopped at any time. Common side effects include bloating, nausea, vomiting, diarrhea, and changes in food preferences. However, the injections are considered safe for most patients and have been shown to reduce the risk of heart attacks and strokes.

Leave a Reply